Pioneering a new approach to biological discovery
IPI blends academic exploration with industrial scalability
to tap the full potential of recombinant antibodies.
Our proteins power discovery
IPI is a nonprofit research hybrid that invests in high-throughput technologies and deep protein expertise to bring biological research up to speed.
Academic expertise
Our Harvard-based scientists collaboratively take on complex projects in the areas most in need of transformative antibodies and other proteins.
Industrial platform
We achieve unprecedented scale with a platform and technologies based on high-quality protein and antibody design, expression and production.
IPI in brief

Meeting research needs
IPI scientists deploy cutting-edge technologies and techniques, such as antibody engineering and a yeast display library, to tap the full potential of synthetic recombinant antibodies.

Best of both worlds
IPI combines deep academic expertise with industrial scalability, investing in high-throughput technologies and automation to bring biological research up to speed.

Unique business model
IPI is a nonprofit institute with assured funding and the high-caliber expertise to support exploratory protein research.

Cross-disciplinary connections
IPI is poised to elevate life science communities, collaborating with biologists across specialties and training young scientists.
Building collaborations
IPI believes the best science crosses fields. We draw together multiple disciplines to build antigen and antibody tools for basic biological research and therapeutic discovery.
At IPI Surfacing, panel calls for long-overdue collaboration to improve antibody reliability and accessibility
In a perfect world, antibody reagents would be reliable. Their protein sequences would be accessible. Application testing would have been conducted before sales. And protein tools...
IPI broadens scientific expertise with new talent
In 2022, IPI successfully broadened its expertise and streamlined its pipeline by bringing in new scientists with diverse specialities and interests. These scientists, who've joined IPI...
From president and CEO Ken Fasman: IPI in the midst of an exciting growth year
I joined the Institute for Protein Innovation in November 2022, coming from a long term in executive leadership at The Jackson Laboratory. Trained in biomedical engineering,...
IPI starts new chapter with game-changing gift: A Q&A with Tim Springer
Big philanthropic gifts can be powerful vehicles of transformation for any young organization. With a history of scientific renown and entrepreneurial success, Institute for Protein Innovation...